ORTHOPEDIATRICS CORP (KIDS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 25M 50M 75M Q3 '16: 10.1M Q4 '16: 9.4M Q1 '17: 9.8M Q2 '17: 11.8M Q3 '17: 12.4M Q4 '17: 11.7M Q1 '18: 12.1M Q2 '18: 15.1M Q3 '18: 15.8M Q4 '18: 14.6M Q1 '19: 14.7M Q2 '19: 18.2M Q3 '19: 20.7M Q4 '19: 19M Q1 '20: 16.4M Q2 '20: 13.6M Q3 '20: 22.2M Q4 '20: 18.9M Q1 '21: 21.5M Q2 '21: 26.7M Q3 '21: 25.1M Q4 '21: 24.8M Q1 '22: 23.4M Q2 '22: 32.9M Q3 '22: 35M Q4 '22: 31M Q1 '23: 31.6M Q2 '23: 39.6M Q3 '23: 40M Q4 '23: 37.6M Q1 '24: 44.7M Q2 '24: 52.8M Q3 '24: 54.6M Q4 '24: 52.7M Q1 '25: 52.4M Q2 '25: 61.1M Q3 '25: 61.2M Q4 '25: 61.6M Q1 '26: 59.4M Q2 '26: 70.5M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit Quarterly

0 20M 40M 60M Q3 '16: 7.2M Q4 '16: 6.4M Q1 '17: 7.4M Q2 '17: 8.7M Q3 '17: 9.5M Q4 '17: 8.8M Q1 '18: 8.9M Q2 '18: 11.3M Q3 '18: 12M Q4 '18: 10.5M Q1 '19: 10.7M Q2 '19: 13.6M Q3 '19: 15.9M Q4 '19: 14.4M Q1 '20: 12.2M Q2 '20: 10.1M Q3 '20: 17.6M Q4 '20: 15.1M Q1 '21: 16.3M Q2 '21: 20.4M Q3 '21: 18.6M Q4 '21: 18.1M Q1 '22: 18.6M Q2 '22: 25M Q3 '22: 25.9M Q4 '22: 21.2M Q1 '23: 23.6M Q2 '23: 30M Q3 '23: 31M Q4 '23: 26.7M Q1 '24: 32.2M Q2 '24: 40.8M Q3 '24: 40.1M Q4 '24: 35.6M Q1 '25: 38.3M Q2 '25: 44M Q3 '25: 45.3M Q4 '25: 45.1M Q1 '26: 43.4M Q2 '26: 52.4M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Income Quarterly

-15M -10M -5M 0 5M 10M 15M Q3 '16: -523K Q4 '16: -3.3M Q1 '17: -837K Q2 '17: -677K Q3 '17: -756K Q4 '17: -4.2M Q1 '18: -4.4M Q2 '18: -2.1M Q3 '18: -1.2M Q4 '18: -1.9M Q1 '19: -2.7M Q2 '19: -1.8M Q3 '19: -1.5M Q4 '19: -3M Q1 '20: -4.5M Q2 '20: -7M Q3 '20: -2.5M Q4 '20: -12.7M Q1 '21: -6M Q2 '21: -2.8M Q3 '21: -3.6M Q4 '21: -5.6M Q1 '22: -6.4M Q2 '22: -3.7M Q3 '22: -7M Q4 '22: -8.3M Q1 '23: -8.6M Q2 '23: -5.6M Q3 '23: -4.5M Q4 '23: -8.1M Q1 '24: -9.7M Q2 '24: -5.7M Q3 '24: -5.6M Q4 '24: -14.1M Q1 '25: -11M Q2 '25: -10.7M Q3 '25: -9.4M Q4 '25: -8.2M Q1 '26: -8.3M Q2 '26: -4.1M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income Quarterly

-21M -14M -7M 0 7M 14M 21M Q3 '16: -845K Q4 '16: -3.6M Q1 '17: -1.3M Q2 '17: -1.5M Q3 '17: -1.5M Q4 '17: -4.8M Q1 '18: -5M Q2 '18: -2.7M Q3 '18: -1.9M Q4 '18: -2.5M Q1 '19: -3M Q2 '19: -2.6M Q3 '19: -2.7M Q4 '19: -5.4M Q1 '20: -4.9M Q2 '20: -9.4M Q3 '20: -4.5M Q4 '20: -14M Q1 '21: -10.4M Q2 '21: -3.8M Q3 '21: -2.2M Q4 '21: 72K Q1 '22: -9.1M Q2 '22: -333K Q3 '22: 18.5M Q4 '22: -7.8M Q1 '23: -6.8M Q2 '23: -2.9M Q3 '23: -4.6M Q4 '23: -6.7M Q1 '24: -7.8M Q2 '24: -6M Q3 '24: -7.9M Q4 '24: -16.1M Q1 '25: -10.7M Q2 '25: -7.1M Q3 '25: -11.8M Q4 '25: -10.1M Q1 '26: -10.7M Q2 '26: -7.2M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue Quarterly

0 7M 14M 21M Q3 '16: 3M Q4 '16: 6.4M Q1 '17: 2.3M Q2 '17: 3.1M Q3 '17: 2.9M Q4 '17: 2.8M Q1 '18: 3.2M Q2 '18: 3.8M Q3 '18: 3.8M Q4 '18: 4.1M Q1 '19: 4M Q2 '19: 4.6M Q3 '19: 4.8M Q4 '19: 4.5M Q1 '20: 4.1M Q2 '20: 3.5M Q3 '20: 4.6M Q4 '20: 3.8M Q1 '21: 5.1M Q2 '21: 6.3M Q3 '21: 6.5M Q4 '21: 6.7M Q1 '22: 4.9M Q2 '22: 7.9M Q3 '22: 9.1M Q4 '22: 9.8M Q1 '23: 8M Q2 '23: 9.5M Q3 '23: 9M Q4 '23: 10.9M Q1 '24: 12.5M Q2 '24: 12M Q3 '24: 14.5M Q4 '24: 17.1M Q1 '25: 14.1M Q2 '25: 17.1M Q3 '25: 16M Q4 '25: 16.5M Q1 '26: 16M Q2 '26: 18.1M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow Quarterly

-12M -8M -4M 0 4M 8M 12M Q1 '17: -5K Q2 '17: -4.2M Q3 '17: 340K Q4 '17: -3.3M Q1 '18: -5M Q2 '18: -6.6M Q3 '18: -1.2M Q4 '18: -2.7M Q1 '19: -3.5M Q2 '19: -6.9M Q3 '19: -429K Q4 '19: -6.9M Q1 '20: -7M Q2 '20: -7.8M Q3 '20: -3.7M Q4 '20: -157K Q1 '21: -1.9M Q2 '21: -9M Q3 '21: -937K Q4 '21: -1.2M Q1 '22: -4.2M Q2 '22: -8.2M Q3 '22: -6.1M Q4 '22: -3.3M Q1 '23: -6.5M Q2 '23: -4.4M Q3 '23: -8.7M Q4 '23: -7.5M Q1 '24: -6.7M Q2 '24: -6.1M Q3 '24: -10.3M Q4 '24: -4M Q1 '25: -4.2M Q2 '25: -10.5M Q3 '25: -581K Q4 '25: 10.3M Q1 '26: -3.3M Q2 '26: 928K Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow Quarterly

-15M -10M -5M 0 5M 10M 15M Q1 '17: -1.3M Q2 '17: -5.7M Q3 '17: -765K Q4 '17: -4.6M Q1 '18: -7.8M Q2 '18: -8M Q3 '18: -2.3M Q4 '18: -2.8M Q1 '19: -8.4M Q2 '19: -10.5M Q3 '19: -2.5M Q4 '19: -8.2M Q1 '20: -10.9M Q2 '20: -9M Q3 '20: -5M Q4 '20: -4.2M Q1 '21: -4.7M Q2 '21: -10.7M Q3 '21: -2.9M Q4 '21: -2.9M Q1 '22: -8.4M Q2 '22: -13.4M Q3 '22: -7.1M Q4 '22: -3.9M Q1 '23: -11.4M Q2 '23: -10M Q3 '23: -11.1M Q4 '23: -11.4M Q1 '24: -13.2M Q2 '24: -12.8M Q3 '24: -11.7M Q4 '24: -4.2M Q1 '25: -8.4M Q2 '25: -13.9M Q3 '25: -3.4M Q4 '25: 9.7M Q1 '26: -5M Q2 '26: -3.1M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 9M 18M 27M Q1 '20: 16.4M Q2 '20: 17.5M Q3 '20: 19.1M Q1 '21: 19.2M Q2 '21: 19.3M Q3 '21: 19.3M Q1 '22: 19.4M Q2 '22: 19.8M Q3 '22: 21.3M Q1 '23: 22.5M Q2 '23: 22.7M Q3 '23: 22.8M Q1 '24: 22.8M Q2 '24: 23.1M Q3 '24: 23.2M Q1 '25: 23.2M Q2 '25: 23.5M Q3 '25: 23.6M Q1 '26: 23.7M Q2 '26: 24M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-9.00 -6.00 -3.00 0.00 3.00 6.00 9.00 Q4 '16: -7.14 Q1 '17: -6.93 Q2 '17: -7.52 Q3 '17: -7.84 Q4 '17: -6.22 Q1 '18: -5.08 Q2 '18: -3.73 Q3 '18: -2.18 Q4 '18: -0.96 Q1 '19: -0.76 Q2 '19: -0.73 Q3 '19: -0.76 Q4 '19: -0.93 Q1 '20: -1.02 Q2 '20: -1.38 Q3 '20: -1.44 Q4 '20: -1.81 Q1 '21: -2.05 Q2 '21: -1.70 Q3 '21: -1.57 Q4 '21: -0.84 Q1 '22: -0.77 Q2 '22: -0.60 Q3 '22: 0.38 Q4 '22: 0.06 Q1 '23: 0.23 Q2 '23: 0.12 Q3 '23: -0.95 Q4 '23: -0.92 Q1 '24: -0.96 Q2 '24: -1.09 Q3 '24: -1.23 Q4 '24: -1.64 Q1 '25: -1.76 Q2 '25: -1.80 Q3 '25: -1.96 Q4 '25: -1.69 Q1 '26: -1.68 Q2 '26: -1.68 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.